DalsnaFinance › Analyst accuracy › UBS › CI target
UBS reiterates Cigna stock buy rating on 2026-2030 outlook
UBS reiterated a Buy rating and $400.00 price target on Cigna Group stock ([NYSE:CI](https://www.investing.com/equities/cigna-corp)).
A fact about what UBS published, as reported by Investing.com, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.